CramerCalls
-
Stop Trading Like a Fan: If You’re Buying MRVL or BHC, Bring a Plan
Jim Cramer says buy Marvell (MRVL) and Bausch Health (BHC). Fine. But blindly following TV calls is how you end up bag-holding someone else’s conviction. If you’re going to play these, you need levels. You need risk control. And you need a plan for when the story cracks. Let’s break it down like a trader,…
-
Cramer’s Right on Marvell — and Way Too Casual on Bausch’s Risk
When Jim Cramer says “buy,” Wall Street listens. Retail traders sprint. And somewhere, a hedge fund quietly takes the other side. Now he’s bullish on Marvell (MRVL) and Bausch Health (BHC). Two very different beasts — one riding the AI semiconductor wave, the other dragging around a pharmaceutical debt hangover. So the question isn’t whether…
-
Cramer’s Marvell and Bausch Calls Aren’t Crazy — But Timing Is Everything
When Jim Cramer pounds the table, traders listen. They shouldn’t follow blindly — but they should pay attention. His latest calls? Buy Marvell Technology and Bausch Health. Two very different beasts. One riding the AI chip frenzy. The other crawling out of a debt-heavy pharma mess. So is this actionable alpha — or just good…
You must be logged in to post a comment.